Citius Oncology, Inc. (CTOR) Financials

CTOR Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 112.1 million 71.7 million
March 31, 2026 100.7 million 65.4 million
Dec. 31, 2025 110.0 million 51.6 million
Sept. 30, 2025 100.9 million 56.1 million

CTOR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -2.8 million ?
March 31, 2026 -4.0 million 3.5 million
Dec. 31, 2025 -7.4 million 4.0 million
Sept. 30, 2025 -5.5 million 2.3 million

CTOR Net Income

No data available :(

CTOR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 16.6 million 10.2 million -
March 31, 2026 2.6 million 3.8 million -
Dec. 31, 2025 7.3 million 3.8 million -
Sept. 30, 2025 3.9 million 3.8 million -

CTOR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 107.9 million
March 31, 2026 100.0 million
Dec. 31, 2025 87.5 million
Sept. 30, 2025 80.9 million

CTOR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 218496 7.8 million -
March 31, 2026 5 1.1 million 27.2 million -
Dec. 31, 2025 4 1.0 million 6.8 million -
Sept. 30, 2025 5 1.1 million 3.6 million -

CTOR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 1.5 million 2.2 million
March 31, 2026 1.7 million 328878
Dec. 31, 2025 3.9 million 789208
Sept. 30, 2025 - -

CTOR

Price: $0.92

52 week price:
0.49
2.25

Earnings Per Share: -0.48 USD

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 80.0 million

Links: